Goldman Sachs Group Inc Pfizer Inc Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
A detailed history of Goldman Sachs Group Inc transactions in Pfizer Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 32,815,438 shares of PFE stock, worth $823 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
32,815,438
Previous 30,341,914
8.15%
Holding current value
$823 Million
Previous $735 Million
13.68%
% of portfolio
0.11%
Previous 0.1%
Shares
24 transactions
Others Institutions Holding PFE
# of Institutions
3,357Shares Held
3.57BCall Options Held
86.1MPut Options Held
105M-
Vanguard Group Inc Valley Forge, PA534MShares$13.4 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.6 Billion0.27% of portfolio
-
State Street Corp Boston, MA299MShares$7.5 Billion0.27% of portfolio
-
Geode Capital Management, LLC Boston, MA129MShares$3.24 Billion0.22% of portfolio
-
Morgan Stanley New York, NY74.8MShares$1.88 Billion0.12% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $141B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...